Emily S Day (E S Day)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 33

Top Topics

Epithelial Mesenchymal Transition

Breast Cancer Cells

Signaling Pathway

Top Venues

ACS biomaterials science & engineering

Bioengineering & translational medicine

Molecular pharmaceutics

This page only lists publications with an associated author ORCID identifier.

Publications

Mackenzie A Scully, Ruth Wilhelm, Dana E Wilkins, Emily S Day
Membrane-Cloaked Nanoparticles for RNA Interference of β-Catenin in Triple-Negative Breast Cancer. ACS biomaterials science & engineering 10 (3) (2024)
Mackenzie A Scully, Ruth Wilhelm, Dana E Wilkins, Emily S Day
Membrane-Cloaked Nanoparticles for RNA Interference of β-Catenin in Triple-Negative Breast Cancer. ACS biomaterials science & engineering 10 (3) (2024)
Mackenzie A Scully, Ruth Wilhelm, Dana E Wilkins, Emily S Day
Membrane-Cloaked Nanoparticles for RNA Interference of β-Catenin in Triple-Negative Breast Cancer. ACS biomaterials science & engineering (2024)
Elise C Hoover, Olivia M Ruggiero, Rachel N Swingler, Emily S Day
FZD7-Targeted Nanoparticles to Enhance Doxorubicin Treatment of Triple-Negative Breast Cancer. ACS omega 9 (12) (2024)
Mackenzie A Scully, Ruth Wilhelm, Dana E Wilkins, Emily S Day
Membrane-Cloaked Nanoparticles for RNA Interference of β-Catenin in Triple-Negative Breast Cancer. ACS biomaterials science & engineering (2024)
Mackenzie A Scully, Ruth Wilhelm, Dana E Wilkins, Emily S Day
Membrane-Cloaked Nanoparticles for RNA Interference of β-Catenin in Triple-Negative Breast Cancer. ACS biomaterials science & engineering 10 (3) (2024)
Mackenzie A Scully, Ruth Wilhelm, Dana E Wilkins, Emily S Day
Membrane-Cloaked Nanoparticles for RNA Interference of β-Catenin in Triple-Negative Breast Cancer. ACS biomaterials science & engineering 10 (3) (2024)
Mackenzie A Scully, Ruth Wilhelm, Dana E Wilkins, Emily S Day
Membrane-Cloaked Nanoparticles for RNA Interference of β-Catenin in Triple-Negative Breast Cancer. ACS biomaterials science & engineering 10 (3) (2024)
Elise C Hoover, Olivia M Ruggiero, Rachel N Swingler, Emily S Day
FZD7-Targeted Nanoparticles to Enhance Doxorubicin Treatment of Triple-Negative Breast Cancer. ACS omega 9 (12) (2024)
Mackenzie A Scully, Dana E Wilkins, Megan N Dang, Elise C Hoover, Sara B Aboeleneen, Emily S Day
Cancer Cell Membrane Wrapped Nanoparticles for the Delivery of a Bcl-2 Inhibitor to Triple-Negative Breast Cancer. Molecular pharmaceutics (2023)
Sara B Aboeleneen, Mackenzie A Scully, George C Kramarenko, Emily S Day
Combination cancer imaging and phototherapy mediated by membrane-wrapped nanoparticles. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 40 (1) (2023)
Z Fereshteh, Megan N Dang, C Wenck, Emily S Day, John H Slater
E-Selectin Targeted Gold Nanoshells to Inhibit Breast Cancer Cell Binding to Lung Endothelial Cells. ACS applied nano materials 6 (2) (2023)
N'Dea S Irvin-Choy, Katherine M Nelson, Jason P Gleghorn, Emily S Day
Delivery and short-term maternal and fetal safety of vaginally administered PEG-PLGA nanoparticles. Drug delivery and translational research (2023)
Maximilian R J Marek, Trong Nhan Pham, Jianxin Wang, Qiuqi Cai, Glenn P A Yap, Emily S Day, Joel Rosenthal
Isocorrole-Loaded Polymer Nanoparticles for Photothermal Therapy under 980 nm Light Excitation. ACS omega 7 (41) (2022)
Samik Das, Jenna C Harris, Erica J Winter, Chen-Yuan Kao, Emily S Day, Eleftherios Terry Papoutsakis
Megakaryocyte membrane-wrapped nanoparticles for targeted cargo delivery to hematopoietic stem and progenitor cells. Bioengineering & translational medicine 8 (3) (2022)
Sara B Aboeleneen, Mackenzie A Scully, Jenna C Harris, Eric H Sterin, Emily S Day
Membrane-wrapped nanoparticles for photothermal cancer therapy. Nano convergence 9 (1) (2022)
Mackenzie A Scully, Eric H Sterin, Emily S Day
Membrane-wrapped nanoparticles for nucleic acid delivery. Biomaterials science 10 (16) (2022)
Samik Das, Jenna C Harris, Erica J Winter, Chen-Yuan Kao, Emily S Day, Eleftherios Terry Papoutsakis
Megakaryocyte membrane-wrapped nanoparticles for targeted cargo delivery to hematopoietic stem and progenitor cells. Bioengineering & translational medicine 8 (3) (2022)
Samik Das, Jenna C Harris, Erica J Winter, Chen-Yuan Kao, Emily S Day, Eleftherios Terry Papoutsakis
Megakaryocyte membrane-wrapped nanoparticles for targeted cargo delivery to hematopoietic stem and progenitor cells. Bioengineering & translational medicine 8 (3) (2022)
Jenna C Harris, Eric H Sterin, Emily S Day
Membrane-Wrapped Nanoparticles for Enhanced Chemotherapy of Acute Myeloid Leukemia. ACS biomaterials science & engineering 8 (10) (2022)
Shoaib Iqbal, Benjamin Luo, Jilian R Melamed, Emily S Day
Critical Evaluation of Different Lysosomal Labeling Methods Used to Analyze RNA Nanocarrier Trafficking in Cells. Bioconjugate chemistry 32 (10) (2021)
Danielle M Valcourt, Chintan H Kapadia, Mackenzie A Scully, Megan N Dang, Emily S Day
Best Practices for Preclinical In Vivo Testing of Cancer Nanomedicines. Advanced healthcare materials 9 (12) (2020)
Megan N Dang, Carolina Gomez Casas, Emily S Day
Photoresponsive miR-34a/Nanoshell Conjugates Enable Light-Triggered Gene Regulation to Impair the Function of Triple-Negative Breast Cancer Cells. Nano letters 21 (1) (2020)
Danielle M Valcourt, Megan N Dang, Mackenzie A Scully, Emily S Day
Nanoparticle-Mediated Co-Delivery of Notch-1 Antibodies and ABT-737 as a Potent Treatment Strategy for Triple-Negative Breast Cancer. ACS nano 14 (3) (2020)
D M Valcourt, M N Dang, J Wang, Emily S Day
Nanoparticles for Manipulation of the Developmental Wnt, Hedgehog, and Notch Signaling Pathways in Cancer. Annals of biomedical engineering 48 (7) (2019)
Chintan H Kapadia, Benjamin Luo, Megan N Dang, N'Dea Irvin-Choy, Danielle M Valcourt, Emily S Day
Polymer nanocarriers for MicroRNA delivery. Journal of applied polymer science 137 (25) (2019)
Chintan H Kapadia, Stephen A Ioele, Emily S Day
Layer-by-layer assembled PLGA nanoparticles carrying miR-34a cargo inhibit the proliferation and cell cycle progression of triple-negative breast cancer cells. Journal of biomedical materials research. Part A 108 (3) (2019)
Ritu Goyal, Chintan H Kapadia, Jilian R Melamed, Rachel S Riley, Emily S Day
Layer-by-layer assembled gold nanoshells for the intracellular delivery of miR-34a. Cellular and molecular bioengineering 11 (5) (2018)
Jilian R Melamed, Stephen A Ioele, Ariel J Hannum, Violet M Ullman, Emily S Day
Polyethylenimine-Spherical Nucleic Acid Nanoparticles against Gli1 Reduce the Chemoresistance and Stemness of Glioblastoma Cells. Molecular pharmaceutics 15 (11) (2018)
Rachel S Riley, Rachel K O'Sullivan, Andrea M Potocny, Joel Rosenthal, Emily S Day
Evaluating Nanoshells and a Potent Biladiene Photosensitizer for Dual Photothermal and Photodynamic Therapy of Triple Negative Breast Cancer Cells. Nanomaterials (Basel, Switzerland) 8 (9) (2018)
Chintan H Kapadia, Jilian R Melamed, Emily S Day
Spherical Nucleic Acid Nanoparticles: Therapeutic Potential. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 32 (4) (2018)
Margaret M Billingsley, Rachel S Riley, Emily S Day
Antibody-nanoparticle conjugates to enhance the sensitivity of ELISA-based detection methods. PloS one 12 (5) (2017)
Rachel S Riley, Emily S Day
Frizzled7 Antibody-Functionalized Nanoshells Enable Multivalent Binding for Wnt Signaling Inhibition in Triple Negative Breast Cancer Cells. Small (Weinheim an der Bergstrasse, Germany) 13 (26) (2017)